NCT06357221 - A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

July 18, 2024

Study Completion Date

July 18, 2024

Conditions

Plaque PsoriasisPsoriasis

Interventions

DRUG

Cetaphil

Subjects will clean the skin with Cetaphil Gentle Skin Cleanser, and apply Cetaphil Moisturizing Cream to the lesion areas at least twice daily. Subjects will use Cetaphil Daily Facial Moisturizer SPF 35 as needed.

Trial Locations (3)

27262

Dermatology Consulting Services, High Point

30135

Southeast Dermatology Specialists, LLC, Douglasville

31904

Southeast Dermatology Specialists, LLC, Columbus